Carregant...
Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study
Immune checkpoint inhibitors (ICPIs) agents can cause endocrine immune-related adverse events (irAEs).Aim. Determine the incidence, time of onset and risk factors of endocrine irAEs in cancer patients treated with anti-PD1 and anti-CTLA-4 immunotherapy.Materials and methods. This is a retrospective...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
2019-12-01
|
| Col·lecció: | Сеченовский вестник |
| Matèries: | |
| Accés en línia: | https://www.sechenovmedj.com/jour/article/view/175 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|